Top Markets
Coin of the day
Antisense Therapeutics Limited Antisense Therapeutics Limited

Antisense Therapeutics Limited

ANP
Rangering i aksjer #33638
Antisense Therapeutics Limited, an Australian company headquartered in Toorak... Antisense Therapeutics Limited, an Australian company headquartered in Toorak and founded in 2000, specializes in the research and advancement of innovative antisense pharmaceutical drugs. Its primary pipeline asset, ATL1102, is an antisense inhibitor designed to target CD49d, which is currently in Phase II clinical trials for treating various inflammatory conditions such as multiple sclerosis, Duchenne Muscular Dystrophy, and asthma. Another promising therapeutic in their portfolio is ATL1103, a second-generation antisense drug that aims to block growth hormone receptor expression, thereby lowering insulin-like growth factor-I levels in the blood, and has completed Phase II clinical trials for conditions stemming from excessive growth hormone action.
Aksjekurs
$0.03702159
Sist synkronisert: 2024-01-29
Markedsverdi
$7.21M
Endring (1 dag)
-3.08%
Endring (1 år)
0.00%
Land
AU
Handel Antisense Therapeutics Limited (ANP)

Kategori

Aksjeprishistorikk for Antisense Therapeutics Limited (ANP)
Høyeste sluttskurs: $0.04 den 2024-01-01

Laveste sluttskurs: $0.89 den 2001-12-01
Aksjeprishistorikk for Antisense Therapeutics Limited fra 2001 til 2026
Årlig aksjeprisytelse
År Ytelse
2024 3.20%
2023 -37.05%
2022 -56.36%
2021 59.69%
2020 44.65%
2019 191.58%
2018 3.71%
2017 -27.93%
2016 -45.26%
2015 -30.97%
2014 -50.82%
2013 16.96%
2012 -52.56%
2011 252.85%
2010 -78.09%
2009 107.28%
2008 -31.61%
2007 18.43%
2006 15.79%
2005 -72.58%
2004 4.39%
2003 129.21%
2002 -69.82%
2001 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$171.67 -
DE
$161.67 23.26%
DE
$35.97 20.03%
JP
$225.00 37.51%
CH
$21.04 12.40%
IN